Therapeutic problems in patients with congenital adrenal hyperplasia from 11-β-hydroxylase deficiency
Congenital adrenal hyperplasia (CAH) with 11-β-hydroxylase deficiency accounts for a small percentage of the overall incidence of this disease in the population. The described case of two sisters touches on the therapeutic problems encountered during the treatment of this rare condition. The authors...
Saved in:
Main Authors: | Anita Ptak (Author), Katarzyna Podyma (Author), Dariusz Kajdaniuk (Author) |
---|---|
Format: | Book |
Published: |
Śląski Uniwersytet Medyczny w Katowicach,
2024-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Birth Size in Neonates with Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
by: Helmuth G. Dörr, et al.
Published: (2019) -
Miscarriages in families with an offspring that have classic congenital adrenal hyperplasia and 21-hydroxylase deficiency
by: Helmuth G. Dörr, et al.
Published: (2018) -
Concurrence of Meningomyelocele and Salt-Wasting Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
by: Heves Kırmızıbekmez, et al.
Published: (2015) -
Update on the Swedish Newborn Screening for Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
by: Rolf H. Zetterström, et al.
Published: (2020) -
Congenital adrenal hyperplasia due to 17-alpha hydroxylase deficiency with hypertensive encephalopathy, hypoglycemic seizures and adrenal insufficiency
by: Narendra Kumar
Published: (2018)